Abbie Celniker Shares Her View of Pharma, Ophthalmology from High-flying Third Rock Ventures
[creativ_pullleft colour=”light-gray” colour_custom=”” text=”Episode 121″]
Ophthalmology CEO turned VC Abbie Celniker, now a partner at Third Rock Ventures, discusses her role at the firm and reveals how it will invest its new $616 million fund.
Abbie C. Celniker, PhD
Abbie Celniker joined Third Rock in 2016 bringing 30 years of experience in R&D and senior leadership roles. Abbie focuses on the formation, development and strategy of our portfolio companies and has assumed active leadership roles…